{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T15:51:40Z","timestamp":1791042700283,"version":"4.1.0"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2012,12,11]],"date-time":"2012-12-11T00:00:00Z","timestamp":1355184000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Rev Endocrinol"],"published-print":{"date-parts":[[2013,2]]},"DOI":"10.1038\/nrendo.2012.230","type":"journal-article","created":{"date-parts":[[2012,12,11]],"date-time":"2012-12-11T10:08:10Z","timestamp":1355220490000},"page":"104-112","source":"Crossref","is-referenced-by-count":111,"title":["Role of KCNJ5 in familial and sporadic primary aldosteronism"],"prefix":"10.1038","volume":"9","author":[{"given":"Paolo","family":"Mulatero","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Monticone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William E.","family":"Rainey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franco","family":"Veglio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tracy Ann","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,12,11]]},"reference":[{"key":"BFnrendo2012230_CR1","doi-asserted-by":"publisher","first-page":"3266","DOI":"10.1210\/jc.2008-0104","volume":"93","author":"JW Funder","year":"2008","unstructured":"Funder, J. W. et al. Case detection, diagnosis, and treatment of patients with primary aldosteronism: an Endocrine Society clinical practice guideline. J. Clin. Endocrinol. Metab. 93, 3266\u20133281 (2008).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrendo2012230_CR2","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1210\/jc.2003-031337","volume":"89","author":"P Mulatero","year":"2004","unstructured":"Mulatero, P. et al. Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents. J. Clin. Endocrinol. Metab. 89, 1045\u20131050 (2004).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrendo2012230_CR3","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1016\/j.jacc.2005.01.015","volume":"45","author":"P Milliez","year":"2005","unstructured":"Milliez, P. et al. Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism. J. Am. Coll. Cardiol. 45, 1243\u20131248 (2005).","journal-title":"J. Am. Coll. Cardiol."},{"key":"BFnrendo2012230_CR4","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1001\/archinternmed.2007.33","volume":"168","author":"C Catena","year":"2008","unstructured":"Catena, C. et al. Cardiovascular outcomes in patients with primary aldosteronism after treatment. Arch. Intern. Med. 168, 80\u201385 (2008).","journal-title":"Arch. Intern. Med."},{"key":"BFnrendo2012230_CR5","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1210\/jc.2005-1733","volume":"91","author":"F Fallo","year":"2006","unstructured":"Fallo, F. et al. Prevalence and characteristics of the metabolic syndrome in primary aldosteronism. J. Clin. Endocrinol. Metab. 91, 454\u2013459 (2006).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrendo2012230_CR6","doi-asserted-by":"publisher","first-page":"329","DOI":"10.7326\/0003-4819-151-5-200909010-00007","volume":"151","author":"MJ Kempers","year":"2009","unstructured":"Kempers, M. J. et al. Systematic review: diagnostic procedures to differentiate unilateral from bilateral adrenal abnormality in primary aldosteronism. Ann. Intern. Med. 151, 329\u2013337 (2009).","journal-title":"Ann. Intern. Med."},{"key":"BFnrendo2012230_CR7","first-page":"1109","volume":"95","author":"DJ Sutherland","year":"1966","unstructured":"Sutherland, D. J., Ruse, J. L. & Laidlaw, J. C. Hypertension, increased aldosterone secretion and low plasma renin activity relieved by dexamethasone. Can. Med. Assoc. J. 95, 1109\u20131119 (1966).","journal-title":"Can. Med. Assoc. J."},{"key":"BFnrendo2012230_CR8","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1161\/HYPERTENSIONAHA.111.175083","volume":"58","author":"P Mulatero","year":"2011","unstructured":"Mulatero, P. et al. Prevalence and characteristics of familial hyperaldosteronism: the PATOGEN study (Primary Aldosteronism in TOrino\u2014GENetic forms). Hypertension 58, 797\u2013803 (2011).","journal-title":"Hypertension"},{"key":"BFnrendo2012230_CR9","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.ecl.2011.01.007","volume":"40","author":"M Stowasser","year":"2011","unstructured":"Stowasser, M., Pimenta, E. & Gordon, R. D. Familial or genetic primary aldosteronism and Gordon syndrome. Endocrinol. Metab. Clin. North Am. 40, 343\u2013368 viii (2011).","journal-title":"Endocrinol. Metab. Clin. North Am."},{"key":"BFnrendo2012230_CR10","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1038\/355262a0","volume":"355","author":"RP Lifton","year":"1992","unstructured":"Lifton, R. P. et al. A chimaeric 11 beta-hydroxylase\/aldosterone synthase gene causes glucocorticoid-remediable aldosteronism and human hypertension. Nature 355, 262\u2013265 (1992).","journal-title":"Nature"},{"key":"BFnrendo2012230_CR11","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1161\/HYPERTENSIONAHA.111.172916","volume":"57","author":"P Mulatero","year":"2011","unstructured":"Mulatero, P., Williams, T. A., Monticone, S. & Veglio, F. Is familial hyperaldosteronism underdiagnosed in hypertensive children? Hypertension 57, 1053\u20131055 (2011).","journal-title":"Hypertension"},{"key":"BFnrendo2012230_CR12","doi-asserted-by":"publisher","first-page":"2236","DOI":"10.1172\/JCI118279","volume":"96","author":"L Pascoe","year":"1995","unstructured":"Pascoe, L. et al. Glucocorticoid-suppressible hyperaldosteronism and adrenal tumors occurring in a single French pedigree. J. Clin. Invest. 96, 2236\u20132246 (1995).","journal-title":"J. Clin. Invest."},{"key":"BFnrendo2012230_CR13","doi-asserted-by":"publisher","first-page":"8327","DOI":"10.1073\/pnas.89.17.8327","volume":"89","author":"L Pascoe","year":"1992","unstructured":"Pascoe, L. et al. Glucocorticoid-suppressible hyperaldosteronism results from hybrid genes created by unequal crossovers between CYP11B1 and CYP11B2. Proc. Natl Acad. Sci. USA 89, 8327\u20138331 (1992).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrendo2012230_CR14","first-page":"1507","volume":"82","author":"WR Litchfield","year":"1997","unstructured":"Litchfield, W. R. et al. Impaired potassium-stimulated aldosterone production: a possible explanation for normokalemic glucocorticoid-remediable aldosteronism. J. Clin. Endocrinol. Metab. 82, 1507\u20131510 (1997).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrendo2012230_CR15","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1067\/mpd.2001.112648","volume":"138","author":"RG Dluhy","year":"2001","unstructured":"Dluhy, R. G., Anderson, B., Harlin, B., Ingelfinger, J. & Lifton, R. Glucocorticoid-remediable aldosteronism is associated with severe hypertension in early childhood. J. Pediatr. 138, 715\u2013720 (2001).","journal-title":"J. Pediatr."},{"key":"BFnrendo2012230_CR16","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1161\/01.HYP.31.1.445","volume":"31","author":"WR Litchfield","year":"1998","unstructured":"Litchfield, W. R., Anderson, B. F., Weiss, R. J., Lifton, R. P. & Dluhy, R. G. Intracranial aneurysm and hemorrhagic stroke in glucocorticoid-remediable aldosteronism. Hypertension 31, 445\u2013450 (1998).","journal-title":"Hypertension"},{"key":"BFnrendo2012230_CR17","first-page":"2160","volume":"85","author":"M Stowasser","year":"2000","unstructured":"Stowasser, M., Bachmann, A. W., Huggard, P. R., Rossetti, T. R. & Gordon, R. D. Severity of hypertension in familial hyperaldosteronism type I: relationship to gender and degree of biochemical disturbance. J. Clin. Endocrinol. Metab. 85, 2160\u20132166 (2000).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrendo2012230_CR18","doi-asserted-by":"publisher","first-page":"3187","DOI":"10.1210\/jcem.87.7.8647","volume":"87","author":"P Mulatero","year":"2002","unstructured":"Mulatero, P. et al. Glucocorticoid remediable aldosteronism: low morbidity and mortality in a four-generation Italian pedigree. J. Clin. Endocrinol. Metab. 87, 3187\u20133191 (2002).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrendo2012230_CR19","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/sj.jhh.1001636","volume":"18","author":"F Fallo","year":"2004","unstructured":"Fallo, F. et al. Coexistence of different phenotypes in a family with glucocorticoid-remediable aldosteronism. J. Hum. Hypertens. 18, 47\u201351 (2004).","journal-title":"J. Hum. Hypertens."},{"key":"BFnrendo2012230_CR20","first-page":"3996","volume":"83","author":"P Mulatero","year":"1998","unstructured":"Mulatero, P. et al. Recombinant CYP11B genes encode enzymes that can catalyze conversion of 11-deoxycortisol to cortisol, 18-hydroxycortisol, and 18-oxocortisol. J. Clin. Endocrinol. Metab. 83, 3996\u20134001 (1998).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrendo2012230_CR21","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1161\/HYPERTENSIONAHA.110.168740","volume":"57","author":"M Aglony","year":"2011","unstructured":"Aglony, M. et al. Frequency of familial hyperaldosteronism type 1 in a hypertensive pediatric population: clinical and biochemical presentation. Hypertension 57, 1117\u20131121 (2011).","journal-title":"Hypertension"},{"key":"BFnrendo2012230_CR22","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1097\/01.hjh.0000174299.66369.26","volume":"23","author":"A So","year":"2005","unstructured":"So, A. et al. Familial hyperaldosteronism type II is linked to the chromosome 7p22 region but also shows predicted heterogeneity. J. Hypertens. 23, 1477\u20131484 (2005).","journal-title":"J. Hypertens."},{"key":"BFnrendo2012230_CR23","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1136\/jmg.37.11.831","volume":"37","author":"AR Lafferty","year":"2000","unstructured":"Lafferty, A. R. et al. A novel genetic locus for low renin hypertension: familial hyperaldosteronism type II maps to chromosome 7 (7p22). J. Med. Genet. 37, 831\u2013835 (2000).","journal-title":"J. Med. Genet."},{"key":"BFnrendo2012230_CR24","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1097\/HJH.0b013e3283028352","volume":"26","author":"N Sukor","year":"2008","unstructured":"Sukor, N. et al. Further evidence for linkage of familial hyperaldosteronism type II at chromosome 7p22 in Italian as well as Australian and South American families. J. Hypertens. 26, 1577\u20131582 (2008).","journal-title":"J. Hypertens."},{"key":"BFnrendo2012230_CR25","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1161\/01.HYP.0000258554.87444.91","volume":"49","author":"C Newton-Cheh","year":"2007","unstructured":"Newton-Cheh, C. et al. Clinical and genetic correlates of aldosterone-to-renin ratio and relations to blood pressure in a community sample. Hypertension 49, 846\u2013856 (2007).","journal-title":"Hypertension"},{"key":"BFnrendo2012230_CR26","doi-asserted-by":"publisher","first-page":"3117","DOI":"10.1210\/jc.2008-0594","volume":"93","author":"DS Geller","year":"2008","unstructured":"Geller, D. S. et al. A novel form of human mendelian hypertension featuring nonglucocorticoid-remediable aldosteronism. J. Clin. Endocrinol. Metab. 93, 3117\u20133123 (2008).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrendo2012230_CR27","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1126\/science.1198785","volume":"331","author":"M Choi","year":"2011","unstructured":"Choi, M. et al. K+ channel mutations in adrenal aldosterone-producing adenomas and hereditary hypertension. Science 331, 768\u2013772 (2011).","journal-title":"Science"},{"key":"BFnrendo2012230_CR28","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1113\/jphysiol.2004.074047","volume":"562","author":"C Marionneau","year":"2005","unstructured":"Marionneau, C. et al. Specific pattern of ionic channel gene expression associated with pacemaker activity in the mouse heart. J. Physiol. 562, 223\u2013234 (2005).","journal-title":"J. Physiol."},{"key":"BFnrendo2012230_CR29","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1113\/jphysiol.2007.140772","volume":"585","author":"E Mintert","year":"2007","unstructured":"Mintert, E. et al. Generation of a constitutive Na+-dependent inward-rectifier current in rat adult atrial myocytes by overexpression of Kir3.4. J. Physiol. 585, 3\u201313 (2007).","journal-title":"J. Physiol."},{"key":"BFnrendo2012230_CR30","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1182\/blood-2004-01-0069","volume":"104","author":"H Shankar","year":"2004","unstructured":"Shankar, H. et al. Role of G protein-gated inwardly rectifying potassium channels in P2Y12 receptor-mediated platelet functional responses. Blood 104, 1335\u20131343 (2004).","journal-title":"Blood"},{"key":"BFnrendo2012230_CR31","doi-asserted-by":"publisher","first-page":"27499","DOI":"10.1074\/jbc.273.42.27499","volume":"273","author":"S Corey","year":"1998","unstructured":"Corey, S. & Clapham, D. E. Identification of native atrial G-protein-regulated inwardly rectifying K+ (GIRK4) channel homomultimers. J. Biol. Chem. 273, 27499\u201327504 (1998).","journal-title":"J. Biol. Chem."},{"key":"BFnrendo2012230_CR32","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/S0896-6273(00)80438-9","volume":"20","author":"K Wickman","year":"1998","unstructured":"Wickman, K., Nemec, J., Gendler, S. J. & Clapham, D. E. Abnormal heart rate regulation in GIRK4 knockout mice. Neuron 20, 103\u2013114 (1998).","journal-title":"Neuron"},{"key":"BFnrendo2012230_CR33","doi-asserted-by":"publisher","first-page":"2136","DOI":"10.1016\/S0735-1097(01)01304-3","volume":"37","author":"P Kovoor","year":"2001","unstructured":"Kovoor, P. et al. Evaluation of the role of I(KACh) in atrial fibrillation using a mouse knockout model. J. Am. Coll. Cardiol. 37, 2136\u20132143 (2001).","journal-title":"J. Am. Coll. Cardiol."},{"key":"BFnrendo2012230_CR34","doi-asserted-by":"publisher","first-page":"8148","DOI":"10.1073\/pnas.0803261105","volume":"105","author":"CA Perry","year":"2008","unstructured":"Perry, C. A. et al. Predisposition to late-onset obesity in GIRK4 knockout mice. Proc. Natl Acad. Sci. USA 105, 8148\u20138153 (2008).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrendo2012230_CR35","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1016\/j.ajhg.2010.04.017","volume":"86","author":"Y Yang","year":"2010","unstructured":"Yang, Y. et al. Identification of a Kir3.4 mutation in congenital long QT syndrome. Am. J. Hum. Genet. 86, 872\u2013880 (2010).","journal-title":"Am. J. Hum. Genet."},{"key":"BFnrendo2012230_CR36","doi-asserted-by":"publisher","first-page":"E1567","DOI":"10.1210\/jc.2011-3132","volume":"97","author":"S Monticone","year":"2012","unstructured":"Monticone, S. et al. Effect of KCNJ5 mutations on gene expression in aldosterone-producing adenomas and adrenocortical cells. J. Clin. Endocrinol. Metab. 97, E1567\u2013E1572 (2012).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrendo2012230_CR37","doi-asserted-by":"publisher","first-page":"E819","DOI":"10.1210\/jc.2011-2965","volume":"97","author":"EA Azizan","year":"2012","unstructured":"Azizan, E. A. et al. Microarray, qPCR, and KCNJ5 sequencing of aldosterone-producing adenomas reveal differences in genotype and phenotype between zona glomerulosa- and zona fasciculata-like tumors. J. Clin. Endocrinol. Metab. 97, E819\u2013E829 (2012).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrendo2012230_CR38","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.mce.2003.10.046","volume":"217","author":"A Sp\u00e4t","year":"2004","unstructured":"Sp\u00e4t, A. Glomerulosa cell\u2014a unique sensor of extracellular K+ concentration. Mol. Cell. Endocrinol. 217, 23\u201326 (2004).","journal-title":"Mol. Cell. Endocrinol."},{"key":"BFnrendo2012230_CR39","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1055\/s-0029-1243601","volume":"42","author":"S Bandulik","year":"2010","unstructured":"Bandulik, S., Penton, D., Barhanin, J. & Warth, R. TASK1 and TASK3 potassium channels: determinants of aldosterone secretion and adrenocortical zonation. Horm. Metab. Res. 42, 450\u2013457 (2010).","journal-title":"Horm. Metab. Res."},{"key":"BFnrendo2012230_CR40","doi-asserted-by":"publisher","first-page":"3651","DOI":"10.1210\/en.2001-211359","volume":"143","author":"JC Condon","year":"2002","unstructured":"Condon, J. C., Pezzi, V., Drummond, B. M., Yin, S. & Rainey, W. E. Calmodulin-dependent kinase I regulates adrenal cell expression of aldosterone synthase. Endocrinology 143, 3651\u20133657 (2002).","journal-title":"Endocrinology"},{"key":"BFnrendo2012230_CR41","doi-asserted-by":"publisher","first-page":"4328","DOI":"10.1210\/en.2012-1241","volume":"153","author":"K Oki","year":"2012","unstructured":"Oki, K., Plonczynski, M. W., Lam, M. L., Gomez-Sanchez, E. P. & Gomez-Sanchez, C. E. The potassium channel, Kir3.4 participates in angiotensin II-stimulated aldosterone production by a human adrenocortical cell line. Endocrinology 153, 4328\u20134335 (2012).","journal-title":"Endocrinology"},{"key":"BFnrendo2012230_CR42","first-page":"E303","volume":"276","author":"PE McEwan","year":"1999","unstructured":"McEwan, P. E., Vinson, G. P. & Kenyon, C. J. Control of adrenal cell proliferation by AT1 receptors in response to angiotensin II and low-sodium diet. Am. J. Physiol. 276, E303\u2013E309 (1999).","journal-title":"Am. J. Physiol."},{"key":"BFnrendo2012230_CR43","doi-asserted-by":"publisher","first-page":"2972","DOI":"10.1210\/jc.2008-1241","volume":"93","author":"P Mulatero","year":"2008","unstructured":"Mulatero, P. A new form of hereditary primary aldosteronism: familial hyperaldosteronism type III. J. Clin. Endocrinol. Metab. 93, 2972\u20132974 (2008).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrendo2012230_CR44","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1161\/HYPERTENSIONAHA.111.183996","volume":"59","author":"P Mulatero","year":"2012","unstructured":"Mulatero, P. et al. KCNJ5 mutations in European families with nonglucocorticoid remediable familial hyperaldosteronism. Hypertension 59, 235\u2013240 (2012).","journal-title":"Hypertension"},{"key":"BFnrendo2012230_CR45","doi-asserted-by":"publisher","first-page":"2533","DOI":"10.1073\/pnas.1121407109","volume":"109","author":"UI Scholl","year":"2012","unstructured":"Scholl, U. I. et al. Hypertension with or without adrenal hyperplasia due to different inherited mutations in the potassium channel KCNJ5. Proc. Natl Acad. Sci. USA 109, 2533\u20132538 (2012).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrendo2012230_CR46","doi-asserted-by":"publisher","first-page":"E1532","DOI":"10.1210\/jc.2012-1334","volume":"97","author":"E Charmandari","year":"2012","unstructured":"Charmandari, E. et al. A novel point mutation in the KCNJ5 gene causing primary hyperaldosteronism and early-onset autosomal dominant hypertension. J. Clin. Endocrinol. Metab. 97, E1532\u20131539 (2012).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrendo2012230_CR47","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1161\/HYPERTENSIONAHA.111.186478","volume":"59","author":"S Boulkroun","year":"2012","unstructured":"Boulkroun, S. et al. Prevalence, clinical, and molecular correlates of KCNJ5 mutations in primary aldosteronism. Hypertension 59, 592\u2013598 (2012).","journal-title":"Hypertension"},{"key":"BFnrendo2012230_CR48","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1530\/ERC-12-0022","volume":"19","author":"P Xekouki","year":"2012","unstructured":"Xekouki, P. et al. KCNJ5 mutations in the National Institutes of Health cohort of patients with primary hyperaldosteronism: an infrequent genetic cause of Conn's syndrome. Endocr. Relat. Cancer 19, 255\u2013260 (2012).","journal-title":"Endocr. Relat. Cancer"},{"key":"BFnrendo2012230_CR49","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1161\/HYPERTENSIONAHA.111.186239","volume":"59","author":"EA Azizan","year":"2012","unstructured":"Azizan, E. A. et al. Somatic mutations affecting the selectivity filter of KCNJ5 are frequent in 2 large unselected collections of adrenal aldosteronomas. Hypertension 59, 587\u2013591 (2012).","journal-title":"Hypertension"},{"key":"BFnrendo2012230_CR50","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1210\/jc.2011-2885","volume":"97","author":"R Taguchi","year":"2012","unstructured":"Taguchi, R. et al. Expression and mutations of KCNJ5 mRNA in Japanese patients with aldosterone-producing adenomas. J. Clin. Endocrinol. Metab. 97, 1311\u20131319 (2012).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrendo2012230_CR51","doi-asserted-by":"publisher","first-page":"e41926","DOI":"10.1371\/journal.pone.0041926","volume":"7","author":"T Akerstr\u00f6m","year":"2012","unstructured":"Akerstr\u00f6m, T. et al. Comprehensive re-sequencing of adrenal aldosterone producing lesions reveal three somatic mutations near the KCNJ5 potassium channel selectivity filter. PLoS ONE 7, e41926 (2012).","journal-title":"PLoS ONE"},{"key":"BFnrendo2012230_CR52","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1097\/HJH.0b013e328356139f","volume":"30","author":"M Murthy","year":"2012","unstructured":"Murthy, M., Azizan, E. A., Brown, M. J. & O'Shaughnessy, K. M. Characterization of a novel somatic KCNJ5 mutation delI157 in an aldosterone-producing adenoma. J. Hypertens. 30, 1827\u20131833 (2012).","journal-title":"J. Hypertens."},{"key":"BFnrendo2012230_CR53","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1038\/sj.emboj.7601934","volume":"27","author":"D Heitzmann","year":"2008","unstructured":"Heitzmann, D. et al. Invalidation of TASK1 potassium channels disrupts adrenal gland zonation and mineralocorticoid homeostasis. EMBO J. 27, 179\u2013187 (2008).","journal-title":"EMBO J."},{"key":"BFnrendo2012230_CR54","doi-asserted-by":"publisher","first-page":"2203","DOI":"10.1073\/pnas.0712000105","volume":"105","author":"LA Davies","year":"2008","unstructured":"Davies, L. A. et al. TASK channel deletion in mice causes primary hyperaldosteronism. Proc. Natl Acad. Sci. USA 105, 2203\u20132208 (2008).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrendo2012230_CR55","doi-asserted-by":"publisher","first-page":"7469","DOI":"10.1038\/sj.onc.1210054","volume":"25","author":"C Niehrs","year":"2006","unstructured":"Niehrs, C. Function and biological roles of the Dickkopf family of Wnt modulators. Oncogene 25, 7469\u20137481 (2006).","journal-title":"Oncogene"},{"key":"BFnrendo2012230_CR56","doi-asserted-by":"publisher","first-page":"4922","DOI":"10.1093\/hmg\/dds333","volume":"21","author":"A El Wakil","year":"2012","unstructured":"El Wakil, A. et al. Dkk3 is a component of the genetic circuitry regulating aldosterone biosynthesis in the adrenal cortex. Hum. Mol. Genet. 21, 4922\u20134929 (2012).","journal-title":"Hum. Mol. Genet."},{"key":"BFnrendo2012230_CR57","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/j.1365-2265.2009.03738.x","volume":"73","author":"EF Nogueira","year":"2010","unstructured":"Nogueira, E. F. et al. The role of TASK1 in aldosterone production and its expression in normal adrenal and aldosterone-producing adenomas. Clin. Endocrinol. (Oxf). 73, 22\u201329 (2010).","journal-title":"Clin. Endocrinol. (Oxf)."},{"key":"BFnrendo2012230_CR58","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1161\/HYPERTENSIONAHA.110.150318","volume":"55","author":"TA Williams","year":"2010","unstructured":"Williams, T. A. et al. Teratocarcinoma-derived growth factor-1 is upregulated in aldosterone-producing adenomas and increases aldosterone secretion and inhibits apoptosis in vitro. Hypertension 55, 1468\u20131475 (2010).","journal-title":"Hypertension"},{"key":"BFnrendo2012230_CR59","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1161\/HYPERTENSIONAHA.111.188250","volume":"60","author":"MC Zennaro","year":"2012","unstructured":"Zennaro, M. C., Jeunemaitre, X. & Boulkroun, S. Integrating genetics and genomics in primary aldosteronism. Hypertension 60, 580\u2013588 (2012).","journal-title":"Hypertension"},{"key":"BFnrendo2012230_CR60","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1161\/HYPERTENSIONAHA.111.186205","volume":"59","author":"CE Gomez-Sanchez","year":"2012","unstructured":"Gomez-Sanchez, C. E. & Gomez-Sanchez, E. P. Mutations of the potassium channel KCNJ5 causing aldosterone-producing adenomas: one or two hits? Hypertension 59, 196\u2013197 (2012).","journal-title":"Hypertension"},{"key":"BFnrendo2012230_CR61","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1161\/HYPERTENSIONAHA.111.188532","volume":"59","author":"TA Williams","year":"2012","unstructured":"Williams, T. A. et al. Visinin-like 1 is upregulated in aldosterone-producing adenomas with KCNJ5 mutations and protects from calcium-induced apoptosis. Hypertension 59, 833\u2013839 (2012).","journal-title":"Hypertension"},{"key":"BFnrendo2012230_CR62","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1007\/s00441-008-0716-3","volume":"335","author":"KH Braunewell","year":"2009","unstructured":"Braunewell, K. H. & Klein-Szanto, A. J. Visinin-like proteins (VSNLs): interaction partners and emerging functions in signal transduction of a subfamily of neuronal Ca2+-sensor proteins. Cell Tissue Res. 335, 301\u2013316 (2009).","journal-title":"Cell Tissue Res."},{"key":"BFnrendo2012230_CR63","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1210\/jc.2011-2384","volume":"97","author":"P Mulatero","year":"2012","unstructured":"Mulatero, P. et al. 18-hydroxycorticosterone, 18-hydroxycortisol, and 18-oxocortisol in the diagnosis of primary aldosteronism and its subtypes. J. Clin. Endocrinol. Metab. 97, 881\u2013889 (2012).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrendo2012230_CR64","doi-asserted-by":"publisher","first-page":"37622","DOI":"10.1074\/jbc.M405431200","volume":"279","author":"MH Bassett","year":"2004","unstructured":"Bassett, M. H. et al. The orphan nuclear receptor NGFIB regulates transcription of 3beta-hydroxysteroid dehydrogenase. implications for the control of adrenal functional zonation. J. Biol. Chem. 279, 37622\u201337630 (2004).","journal-title":"J. Biol. Chem."},{"key":"BFnrendo2012230_CR65","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1210\/en.2009-0977","volume":"151","author":"EF Nogueira","year":"2010","unstructured":"Nogueira, E. F. & Rainey, W. E. Regulation of aldosterone synthase by activator transcription factor\/cAMP response element-binding protein family members. Endocrinology 151, 1060\u20131070 (2010).","journal-title":"Endocrinology"},{"key":"BFnrendo2012230_CR66","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1210\/en.2008-0667","volume":"150","author":"P Ye","year":"2009","unstructured":"Ye, P., Nakamura, Y., Lalli, E. & Rainey, W. E. Differential effects of high and low steroidogenic factor-1 expression on CYP11B2 expression and aldosterone production in adrenocortical cells. Endocrinology 150, 1303\u20131309 (2009).","journal-title":"Endocrinology"},{"key":"BFnrendo2012230_CR67","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.1210\/en.2011-1733","volume":"153","author":"K Oki","year":"2012","unstructured":"Oki, K., Plonczynski, M. W., Luis Lam, M., Gomez-Sanchez, E. P. & Gomez-Sanchez, C. E. Potassium channel mutant KCNJ5 T158A expression in HAC-15 cells increases aldosterone synthesis. Endocrinology 153, 1774\u20131782 (2012).","journal-title":"Endocrinology"},{"key":"BFnrendo2012230_CR68","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.mce.2011.07.034","volume":"350","author":"NG Hattangady","year":"2012","unstructured":"Hattangady, N. G., Olala, L. O., Bollag, W. B. & Rainey, W. E. Acute and chronic regulation of aldosterone production. Mol. Cell. Endocrinol. 350, 151\u2013162 (2012).","journal-title":"Mol. Cell. Endocrinol."},{"key":"BFnrendo2012230_CR69","doi-asserted-by":"publisher","first-page":"4113","DOI":"10.1210\/jc.2004-0069","volume":"89","author":"L Lu","year":"2004","unstructured":"Lu, L. et al. Nur-related factor 1 and nerve growth factor-induced clone B in human adrenal cortex and its disorders. J. Clin. Endocrinol. Metab. 89, 4113\u20134118 (2004).","journal-title":"J. Clin. Endocrinol. Metab."}],"container-title":["Nature Reviews Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nrendo.2012.230.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrendo.2012.230","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrendo.2012.230.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,3]],"date-time":"2024-05-03T04:21:01Z","timestamp":1714710061000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrendo.2012.230"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12,11]]},"references-count":69,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,2]]}},"alternative-id":["BFnrendo2012230"],"URL":"https:\/\/doi.org\/10.1038\/nrendo.2012.230","relation":{},"ISSN":["1759-5029","1759-5037"],"issn-type":[{"value":"1759-5029","type":"print"},{"value":"1759-5037","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,12,11]]}}}